134 related articles for article (PubMed ID: 735704)
1. [Experimental studies on thrombolytic agents. (1) Comparison between prostaglandin E1, heparin and urokinase (author's transl)].
Suzuki T; Takano S
Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):890-6. PubMed ID: 735704
[No Abstract] [Full Text] [Related]
2. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
Fujioka M
Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
[No Abstract] [Full Text] [Related]
3. [Fibrinolytic treatment with urokinase in older phlebothrombosis (author's transl)].
Trübestein G; Brecht T; Glänzer K; Koischwitz D; Etzel F
Med Klin; 1979 Sep; 74(39):1404-11. PubMed ID: 492059
[TBL] [Abstract][Full Text] [Related]
4. [Heparin and urokinase interactions in the fibrinolytic system].
Villaverde CA; Badimón L; Badimón JJ; Valdecasas FG
Arch Farmacol Toxicol; 1979 Dec; 5(3):268-9. PubMed ID: 397804
[No Abstract] [Full Text] [Related]
5. [Fibrinolytic treatment with urokinase of post acute phlebothromboses (author's transl)].
Trübestein G; Brecht T; Etzel F
Dtsch Med Wochenschr; 1979 Aug; 104(35):1241-2. PubMed ID: 477521
[TBL] [Abstract][Full Text] [Related]
6. [Successful fibrinolytic treatment with urokinase six weeks after leg and pelvic vein thrombosis (author's transl)].
Trübestein G; Etzel F; Sobbe A
Dtsch Med Wochenschr; 1974 Nov; 99(48):2457-9. PubMed ID: 4448142
[No Abstract] [Full Text] [Related]
7. [Thrombolytic therapy using urokinase: its mechanism and clinical use (author's transl)].
Sakuragawa N; Takahashi K
Rinsho Ketsueki; 1977 Jun; 18(6):726-31. PubMed ID: 916203
[No Abstract] [Full Text] [Related]
8. [Thrombolytic treatment of deep venous thrombosis].
Martínez-Brotons F; Cairols MA
Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512
[No Abstract] [Full Text] [Related]
9. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinolytic therapy of deep venous thrombosis. Streptokinase, urokinase, plasminogen substitution].
Theiss W; Kriessmann A; Wirtzfeld A
Dtsch Med Wochenschr; 1980 Feb; 105(8):243-6. PubMed ID: 6986252
[No Abstract] [Full Text] [Related]
11. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
12. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
Sakuragawa N
Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
[No Abstract] [Full Text] [Related]
13. [A role of fibrin deposits in the development of rabbit Masugi nephritis and effect of urokinase on the experimental glomerulonephritis (author's transl)].
Akiba T; Tanaka K
Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):125-38. PubMed ID: 7047822
[No Abstract] [Full Text] [Related]
14. Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.
Paolini R; Casonato A; Boeri G; Luzzatto G; Girolami A; Sasahara AA; Cella G
J Med; 1993; 24(2-3):113-30. PubMed ID: 8409776
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic use of thrombolytic agents.
Stambaugh RL; Alexander MR
Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
[TBL] [Abstract][Full Text] [Related]
16. The use of thrombolytic therapy in venous thromboembolic disease.
Rubin RN
Conn Med; 1981 Sep; 45(9):551-4. PubMed ID: 7028391
[No Abstract] [Full Text] [Related]
17. Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
Juhan-Vague I; Stassen JM; Alessi MC; Elias A; Aillaud MF; Serradimigni A; Collen D
Semin Thromb Hemost; 1989 Oct; 15(4):390-4. PubMed ID: 2554499
[No Abstract] [Full Text] [Related]
18. [Low molecular weight heparin and high and low molecular weight urokinase in fibrinolysis in vivo].
Badimón L; Villaverde CA; Vidal M; Valdecasas FG
Arch Farmacol Toxicol; 1979 Dec; 5(3):262-4. PubMed ID: 397803
[No Abstract] [Full Text] [Related]
19. [Thrombolytic therapy. Effect of urokinase on experimental thrombosis (author's transl)].
Kakishita E
Rinsho Ketsueki; 1977 Jun; 18(6):719-25. PubMed ID: 916202
[No Abstract] [Full Text] [Related]
20. [Urokinase therapy of deep vein thrombosis (author's transl)].
Theiss W; Schlund J; Kriessmann A; Lutilsky L; Sauer E; Wirtzfeld A
Klin Wochenschr; 1980 May; 58(10):521-6. PubMed ID: 6993773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
